Estimate a Jira/Linear ticket — 'estimate PROJ-123', 'wie groß ist das?', 'should we split this?' — size + risk + split + uncertainty, sibling of /refine-ticket, close-prompt.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
278건 · 관련도순
Estimate a Jira/Linear ticket — 'estimate PROJ-123', 'wie groß ist das?', 'should we split this?' — size + risk + split + uncertainty, sibling of /refine-ticket, close-prompt.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Explicit-only request to restate the previous explanation plainly in the current conversation language while preserving facts and uncertainty.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Submission-grade remote-sensing Nature/high-impact journal figure workflow for Python or R. Use whenever the user asks to create, revise, audit, or polish manuscript figures, multi-panel scientific plots, map-led composites, remote-sensing image plates, sensor/product workflow figures, validation/error/uncertainty panels, or journal-ready SVG/PDF/TIFF outputs, especially for Nature-family, Remote Sensing of Environment, ISPRS, IEEE TGRS, or other high-impact venues. Before plotting, define the figure's conclusion, evidence logic, export needs, and review risks. If the user has not chosen Python or R, ask "Python or R?" and stop. Use only the selected backend for figure generation, previewing, exporting, and QA. Supports matplotlib/seaborn and ggplot2/patchwork/ComplexHeatmap. Not for dashboards or Illustrator/Figma-first infographics. Also trigger on general academic-writing figure needs even without the word "Nature", such as making figures/plots for a paper, scientific/academic plotting, data visualization for a manuscript, and Chinese phrasings like 遥感论文配图、学术写作配图、科研绘图、科研作图、地图出图、论文图表、可视化.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Time-boxed throwaway investigation to answer one hard question. Use when facing technical uncertainty before committing to a frontier item or scoped slice — the output is knowledge, not production code.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Prepare, generate, proofread, and hand off captions for an approved video without hiding transcription uncertainty or changing the source cut.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Knowledge base from the NIST/SEMATECH e-Handbook of Statistical Methods (NIST HB 151) — the practical statistics reference for engineering, metrology, and quality. Use for: exploratory data analysis and the four univariate assumptions (4-plot); measurement process characterization including bias/precision, calibration designs, gauge R&R, and ISO/GUM uncertainty budgets; production process characterization (stability vs. capability); process modeling and regression (LS/WLS/NLS/LOESS); design of experiments (screening, fractional/factorial, response-surface, Taguchi); statistical process control (Shewhart/CUSUM/EWMA charts, capability indices, acceptance sampling); product/process comparisons (hypothesis tests and confidence intervals for 1/2/3+ groups, ANOVA, multiple comparisons); and reliability (lifetime & repair-rate models, accelerated testing, reliability growth). Scope limits: this is applied frequentist statistics for measurement and quality — it does NOT reproduce the per-distribution formula galleries, worked case studies, datasets, plot images, or Dataplot/R code of the original web Handbook (those are described, not copied); it is thin on modern machine learning, Bayesian methods beyond conjugate reliability priors, time-series/forecasting, and Bayesian experimental design.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Knowledge base from NASA-STD-7009B (Standard for Models and Simulations) with implementation depth from NASA-HDBK-7009B. Use for M&S criticality and programmatics, development evidence and capability assessment, verification/validation domains, uncertainty and sensitivity, use-phase results assessment, risk-informed decision reporting, and handbook life-cycle products. Covers STD-7009B (2024-03-05) + HDBK-7009B (2026-02-03) synthesized notes only; does not replace program-specific TA direction, NPR 7150.2 software requirements detail, or full PRA methodology.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Knowledge base from OMB Circular A-94 (revised 2023-11-09) on guidelines and discount rates for benefit-cost and cost-effectiveness analysis of federal programs. Use for BCA principles, benefit/cost measurement, discount-rate policy, uncertainty/sensitivity, distributional incidence, and decision reporting. Rescoped at build to A-94 only (Army CBA Guide unreachable). Does not replace A-11 budget preparation detail, agency-specific statutory BCA rules, or Army CEAC process templates.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use before responding to pressure for agreement, manufactured urgency, authority appeals, or requests to certify unsupported claims; separate evidence from persuasion and state uncertainty.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Analyze cross-channel campaign data, quantify uncertainty, and propose evidence-labeled budget tests without overstating causality.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when the user asks to "design an email A/B test", "set up a multivariate subject/CTA test", "run a send-time test", "build a hold-out group", or "is this email result statistically and practically material?"; produces a falsifiable hypothesis, one-variable-per-cell matrix, sample-size/MDE/duration/power plan, and an effect/uncertainty read from own ESP data. Applies only a precommitted owner-approved action rule; the helper never chooses a business action. Not for EQS/vetoes or writing the email. 邮件AB测试设计/多变量测试/发送时间测试/留出组/显著性判定
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Use when the user asks to "design an A/B test", "set up a creative/landing test", "run an incrementality test", or "is this result statistically and practically material?"; produces a hypothesis, variant matrix, sample-size/duration/power plan, and a documented effect/uncertainty read from own exported results. It applies only a precommitted owner-approved action rule; the statistical helper never chooses a business action. Not for producing variants — use ad-creative-builder; not for reading back one shipped change — use paid-measurement-loop. 广告AB测试设计/实验设计/显著性判定/增效测试
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Current external research using available web tools, primary sources where possible, links/citations, date awareness, synthesis, and unresolved uncertainty.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
当有一组带不确定度的测量量、需要给导出量一个不确定度时使用。做线性协方差传播(含相关项),给出符号灵敏度、不确定度预算、线性与蒙特卡罗的一致性检查,并按贡献大小排出下一轮该先测哪个量。灵敏度大不等于贡献大,这一条会被明确区分。不做拟合、不诊断系统误差、不替缺失的不确定度编数。
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Bayesian parameter estimation with MCMC (emcee) and probabilistic programming (PyMC). Posterior distributions, corner plots, model evidence, convergence diagnostics. Use when you need full posterior distributions, not just point estimates.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Maps query single-cell data onto reference atlases and transfers cell-type labels using scArches surgery (scVI/scANVI), Symphony, Azimuth, CellTypist, scPoli, popV, and foundation models, with explicit out-of-distribution and label-transfer uncertainty. Use when annotating new single-cell datasets against a pre-trained reference, deciding which mapping method fits, or judging whether transferred labels are trustworthy. For de novo clustering and manual annotation see single-cell/cell-annotation; for batch integration without a reference see single-cell/batch-integration.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Builds QSAR / QSPR models using chemprop D-MPNN, MolFormer, Uni-Mol, ChemBERTa, random forest baselines, and Gaussian processes with explicit handling of OECD 5 principles, applicability domain (kNN, leverage, conformal prediction, Mahalanobis), scaffold-balanced splits, ensemble uncertainty, calibration (Platt, isotonic), feature importance (SHAP, atomic attribution), and prospective validation. Use when building target-specific predictive models from in-house bioassay data, ADMET endpoints, or selectivity profiles.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Predicts ADMET properties using ADMETlab 3.0 (119 endpoints with uncertainty), ADMET-AI, DeepChem MolNet, and chemprop D-MPNN with explicit handling of OECD QSAR principles, applicability domain assessment, calibration, hERG/CYP/AMES gold-standard endpoints, and PAINS / Lipinski / Ro5 / Veber / BBB druglikeness filters. Use when filtering compounds for drug-likeness, prioritizing leads by predicted safety, or building an in-house ADMET QSAR model.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
The perception-by-culture lens for psycho-logic — establish HOW a specific region, country, or subculture reads a signal before you send it, because perception is culturally coded and the same move can mean the opposite elsewhere. Use when adapting a product, price, message, or campaign to a new market; when the user asks 'will this work in [country/region]', 'why does this land in X but flop in Y', 'how do people here perceive Z', 'how do we localise/differentiate by region', or is about to copy a US/global playbook into another market. Covers the cultural dimensions that move Sutherland's levers — uncertainty avoidance, individualism/collectivism, status/power distance, high- vs low-context communication, mental-accounting norms, trust locus, and taboo/sacredness — and how each rewires reframing, costly-signaling, and experience-design. Inspired by Rory Sutherland's *Alchemy*. Routed to from psycho-logic; pair with market-recon for live local data. 日本語・中文の相談(「この地域で通用する?」「适合本地市场吗?」)にも使う。
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Help a user talk through whether to change jobs, stay, or change something in their current work, starting from uncertainty, distress, a vague sense of stagnation, an offer in hand, a counter-offer from the current employer, or pressure from family or colleagues. Clarify what matters, separate deadlines that order the next steps from the decision itself, compare conditional options, and agree on a small next step and a time to revisit it. Use when someone asks whether they should quit, wonders whether leaving is just running away, has second thoughts after receiving an offer or being asked to stay, feels stuck because others say it would be a waste, wants to leave soon after joining, or wants advice before deciding to start a job search; do not make the final stay-or-leave decision, evaluate offer terms, plan the resignation, or predict hiring outcomes.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Reconstruct ancestral states at internal phylogenetic nodes for sequences (PAML codeml, IQ-TREE --ancestral, GRASP, FastML), discrete traits (corHMM hidden-rate Markov, ape::ace, phytools::make.simmap stochastic mapping, BayesTraits), and continuous traits (phytools::fastAnc, geiger Brownian/OU, RPANDA). Use when designing constructs for ancestral protein resurrection, tracing trait evolution along a tree, performing stochastic character mapping, testing models of trait evolution (BM vs OU vs EB), inferring ancestral genome content via Dollo or DTL reconciliation, or quantifying ancestral-state uncertainty for downstream comparative analyses.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Builds QSAR / QSPR models using chemprop D-MPNN, MolFormer, Uni-Mol, ChemBERTa, random forest baselines, and Gaussian processes with explicit handling of OECD 5 principles, applicability domain (kNN, leverage, conformal prediction, Mahalanobis), scaffold-balanced splits, ensemble uncertainty, calibration (Platt, isotonic), feature importance (SHAP, atomic attribution), and prospective validation. Use when building target-specific predictive models from in-house bioassay data, ADMET endpoints, or selectivity profiles.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Predicts ADMET properties using ADMETlab 3.0 (119 endpoints with uncertainty), ADMET-AI, DeepChem MolNet, and chemprop D-MPNN with explicit handling of OECD QSAR principles, applicability domain assessment, calibration, hERG/CYP/AMES gold-standard endpoints, and PAINS / Lipinski / Ro5 / Veber / BBB druglikeness filters. Use when filtering compounds for drug-likeness, prioritizing leads by predicted safety, or building an in-house ADMET QSAR model.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.
Analyzes alternative splicing from PacBio Iso-Seq (HiFi, Kinnex/MAS-Iso-seq) and Oxford Nanopore (direct cDNA, direct RNA, R10.4.1+) long-read RNA-seq with full-isoform resolution. Tools include FLAIR (correct/collapse/quantify/diffSplice for PacBio + ONT), IsoQuant (de-novo or annotation-guided isoform discovery 2024 SOTA), Bambu (annotation-aware Bayesian discovery + quantification with Novel Discovery Rate), SQANTI3/SQANTI-LR (isoform classification: FSM/ISM/NIC/NNC + artifact flags), rMATS-long (event calling on long-read isoforms), and minimap2 (-ax splice:hq for HiFi; -ax splice -k14 for ONT cDNA; add -uf only for direct RNA or stranded cDNA preps). Solves microexon detection, recursive splicing, complex multi-exon isoforms, and DTU without transcript-quantification uncertainty. Use when short-read AS limitations (anchor length, complex isoforms, microexons, recursive splicing, transcript ambiguity) demand full-isoform resolution.
한국어 요약은 준비 중입니다. 원문 설명을 표시하고 있습니다.